J&J Ordered To Pay South Carolina $327 Million For "Detestable" Risperdal Marketing

The award is based on the number of drug samples distributed and Dear Doctor letters issued; South Carolina just filed a similar suit against GlaxoSmithkline over its Avandia marketing.